HUD: Gastric Pacemaker Implantation for Gastroparesis

Sponsor
Indiana University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00568373
Collaborator
(none)
0
1
222

Study Details

Study Description

Brief Summary

Gastric pacemakers and/or temporary gastric stimulators will be implanted in eligible patients.

Condition or Disease Intervention/Treatment Phase
  • Device: Enterra Gastric Pacemaker
N/A

Detailed Description

Due to HUD status, this protocol is for implant only. This is NOT a clinical trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
All patients who have severe symptoms and have been identified by the PI and Sub I to qualify for the treatment will be under one single groupAll patients who have severe symptoms and have been identified by the PI and Sub I to qualify for the treatment will be under one single group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Gastric Electric Stimulation-Enterra Therapy for the Treatment of Chronic Intractable (Drug Refractory) Nausea and Vomiting Secondary to Gastroparesis of Diabetic or Idiopathic Etiology
Anticipated Study Start Date :
Jun 1, 2007
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatement

All subjects that meet the requirement for gastric stimulator placement

Device: Enterra Gastric Pacemaker
Gastric Pacemaker

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Used only if patients have tried and failed conventional treatment ( drug therapy and dietary modification)due to intractable nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Indiana University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Indiana University
    ClinicalTrials.gov Identifier:
    NCT00568373
    Other Study ID Numbers:
    • 0705-32
    First Posted:
    Dec 6, 2007
    Last Update Posted:
    Mar 5, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Indiana University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 5, 2021